Cryo-Cell International, Inc. (CCEL) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Cryo-Cell International, Inc. (CCEL) Bundle
Save time and improve precision with our (CCEL) DCF Calculator! Utilizing real data from Cryo-Cell International, Inc. and customizable assumptions, this tool empowers you to forecast, analyze, and value Cryo-Cell like a seasoned investor.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 31.8 | 31.1 | 28.9 | 30.3 | 31.3 | 31.3 | 31.2 | 31.1 | 31.0 | 30.9 |
| Revenue Growth, % | 0 | -2.1 | -7.26 | 5.03 | 3.32 | -0.25537 | -0.25537 | -0.25537 | -0.25537 | -0.25537 |
| EBITDA | 5.5 | 7.2 | 5.3 | 6.7 | -10.4 | 3.0 | 3.0 | 3.0 | 3.0 | 2.9 |
| EBITDA, % | 17.27 | 23.18 | 18.41 | 21.92 | -33.24 | 9.51 | 9.51 | 9.51 | 9.51 | 9.51 |
| Depreciation | .4 | .6 | 1.3 | 1.8 | 1.7 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 |
| Depreciation, % | 1.26 | 2.04 | 4.59 | 5.96 | 5.46 | 3.86 | 3.86 | 3.86 | 3.86 | 3.86 |
| EBIT | 5.1 | 6.6 | 4.0 | 4.8 | -12.1 | 1.8 | 1.8 | 1.8 | 1.8 | 1.7 |
| EBIT, % | 16.01 | 21.14 | 13.81 | 15.96 | -38.69 | 5.65 | 5.65 | 5.65 | 5.65 | 5.65 |
| Total Cash | 7.4 | 10.4 | 8.3 | 1.7 | 1.0 | 5.9 | 5.9 | 5.9 | 5.9 | 5.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 6.1 | 6.3 | 5.3 | 6.0 | 6.6 | 6.2 | 6.1 | 6.1 | 6.1 | 6.1 |
| Account Receivables, % | 19.16 | 20.3 | 18.19 | 19.92 | 20.98 | 19.71 | 19.71 | 19.71 | 19.71 | 19.71 |
| Inventories | 1.1 | .9 | .9 | .9 | .8 | .9 | .9 | .9 | .9 | .9 |
| Inventories, % | 3.41 | 2.98 | 3.19 | 2.81 | 2.45 | 2.97 | 2.97 | 2.97 | 2.97 | 2.97 |
| Accounts Payable | 1.4 | 1.0 | 1.5 | 1.6 | 3.2 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 |
| Accounts Payable, % | 4.3 | 3.07 | 5.16 | 5.29 | 10.13 | 5.59 | 5.59 | 5.59 | 5.59 | 5.59 |
| Capital Expenditure | -.7 | -.4 | -7.0 | -17.2 | -7.6 | -6.8 | -6.8 | -6.8 | -6.7 | -6.7 |
| Capital Expenditure, % | -2.08 | -1.44 | -24.07 | -56.59 | -24.37 | -21.71 | -21.71 | -21.71 | -21.71 | -21.71 |
| Tax Rate, % | 28.75 | 28.75 | 28.75 | 28.75 | 28.75 | 28.75 | 28.75 | 28.75 | 28.75 | 28.75 |
| EBITAT | 3.4 | 4.7 | 3.2 | 4.0 | -8.6 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -2.6 | 4.4 | -.8 | -11.9 | -13.4 | -5.4 | -4.2 | -4.2 | -4.2 | -4.2 |
| WACC, % | 6.98 | 7.05 | 7.18 | 7.24 | 7.04 | 7.1 | 7.1 | 7.1 | 7.1 | 7.1 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -18.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -4 | |||||||||
| Terminal Value | -84 | |||||||||
| Present Terminal Value | -60 | |||||||||
| Enterprise Value | -78 | |||||||||
| Net Debt | 10 | |||||||||
| Equity Value | -89 | |||||||||
| Diluted Shares Outstanding, MM | 8 | |||||||||
| Equity Value Per Share | -10.61 |
What You Will Receive
- Customizable Excel Template: A fully editable Excel-based DCF Calculator featuring pre-filled financial data for Cryo-Cell International, Inc. (CCEL).
- Accurate Data: Historical figures and future projections (highlighted in the yellow cells).
- Assumption Flexibility: Modify forecast variables such as revenue growth, EBITDA %, and WACC.
- Instant Calculations: Quickly observe how your inputs affect the valuation of Cryo-Cell International, Inc. (CCEL).
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive Layout: Organized for clarity and ease of navigation, complete with step-by-step guidance.
Key Features
- Comprehensive CCEL Data: Pre-loaded with Cryo-Cell International’s historical performance metrics and future forecasts.
- Customizable Assumptions: Modify growth rates, profit margins, discount rates, tax implications, and capital investments.
- Interactive Valuation Framework: Instant recalculations of Net Present Value (NPV) and intrinsic worth based on your parameters.
- Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation possibilities.
- Intuitive User Interface: Clean, organized layout suitable for both experienced professionals and newcomers.
How It Works
- Download the Template: Gain immediate access to the Excel-based CCEL DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
- Instant Calculations: The model automatically recalculates Cryo-Cell International’s intrinsic value.
- Test Scenarios: Explore various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial strategies.
Why Choose This Calculator for Cryo-Cell International, Inc. (CCEL)?
- Accurate Data: Utilizes real Cryo-Cell financials for dependable valuation outcomes.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-configured calculations save you the hassle of starting from square one.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Easy-to-navigate design and comprehensive instructions cater to users of all experience levels.
Who Should Use This Product?
- Investors: Evaluate Cryo-Cell International’s performance before making investment decisions.
- CFOs and Financial Analysts: Enhance financial assessments and validate forecasts.
- Healthcare Entrepreneurs: Understand the valuation methods of leading companies like Cryo-Cell.
- Consultants: Provide detailed valuation analyses for healthcare clients.
- Students and Educators: Utilize current industry data to teach and learn valuation strategies.
What the Template Contains
- Preloaded CCEL Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.